Evidence map›Paper›PMID 23975731›Full record

ArticleApoptosis : an international journal on programmed cell death2013

BH3-only protein Noxa contributes to apoptotic control of stress-erythropoiesis.

Felix M Wensveen, Christian R Geest, Sten F W M Libregts, Ingrid A M Derks, Paul G Ekert, Verena Labi, Andreas Villunger, Martijn A Nolte, Eric Eldering

Open access · hybridAbstract read
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Induction of deubiquitinating enzyme USP50 during erythropoiesis and its potential role in the regulation of Ku70 stability.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2018
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Felix M WensveenDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands. felix.wensveen@gmail.com.
Christian R GeestDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands.
Sten F W M LibregtsDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands.
Ingrid A M DerksDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands.
Paul G EkertDivision of Cell Signaling and Cell Death, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Melbourne, VIC, Australia.
Verena LabiDivision of Developmental Immunology, BIOCENTER, Innsbruck Medical University, Innrain 80-82, 6020, Innsbruck, Austria.
Andreas VillungerDivision of Developmental Immunology, BIOCENTER, Innsbruck Medical University, Innrain 80-82, 6020, Innsbruck, Austria.
Martijn A NolteDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands.
Eric ElderingDepartment of Experimental Immunology, Academic Medical Center, Meibergdreef 8, 1105 AZ, Amsterdam, The Netherlands.
Academic Medical Center · NLInnsbruck Medical University · ATWalter and Eliza Hall Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis plays an essential role in the control of erythropoiesis under normal and pathological conditions. However, the contribution of individual proteins within cell death signalling pathways remains poorly defined. Here, we investigated the role of the pro-apoptotic Bcl-2 family member Noxa in the regulation of erythropoiesis. We found that expression of Noxa is induced during erythroid differentiation of human and murine precursor cells. Using in vitro model systems for erythroid progenitors, we observed rapid induction of Noxa upon cytokine deprivation. Knockdown or deletion of Noxa conferred significant protection against apoptosis upon cytokine withdrawal. In vivo, Noxa deficiency did not affect hematological blood parameters or erythroid progenitor composition of bone marrow and spleen under steady-state conditions. In contrast, in a model of acute haemolytic anemia, Noxa-deficiency enhanced hematocrit recovery. Moreover, in a model of chronic inflammation-induced anemia, Noxa-ablation resulted in a dramatic increase of erythroblast expansion. Our data indicate that induction of Noxa in erythroid progenitors sets a survival threshold that limits expansion beyond the number of cells that can be sustained by the available cytokines, which becomes apparent under conditions of induced anemia.

Indexed as

AnemiaAnimalsApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11Bone MarrowCell DifferentiationCytokinesErythropoiesisGene Expression RegulationHumansMembrane ProteinsMiceMice, KnockoutOxidative StressPhenylhydrazinesApoptosis Regulatory ProteinsBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11CytokinesMembrane ProteinsphenylhydrazinePhenylhydrazinesPmaip1 protein, mouseProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA, Small Interfering

Identifiers

PMID23975731
PMCPMC3825139
OpenAlexW1995388935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.